Drug Database
Back to search

Belgium· BE-AMP-SAM205213-00

Gaviscon Advance

A alginic acid product containing potassium hydrogen carbonate, registered in Belgium by Reckitt Benckiser (Healthcare). The same ATC class is registered in 10 of our 19 countries.

ATC A02BX13

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedGaviscon AdvanceATCA02BX13REGISTER NO.BE-AMP-SAM205213-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about potassium hydrogen carbonateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alginic acid is registered in 10 of 19 countries.

Countries holding a registration under ATC A02BX13 (alginic acid), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search alginic acid products by name

Alginic acid · ATC A02BX13

10 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Potassium Hydrogen Carbonate
Manufacturer
Reckitt Benckiser (Healthcare)
Country
Belgium (BE)
ATC code
A02BX13
ATC class
Alginic acid
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    2476679
  • be_apb
    1478569

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alginic acid in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alginic acid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/720050f1-cd3e-4bf8-81d6-b073b1087fbf
GET /v1/drugs/720050f1-cd3e-4bf8-81d6-b073b1087fbf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Gaviscon Advance",
  "name_fr": "Gaviscon Advance",
  "name_nl": "Gaviscon Advance",
  "amp_code": "SAM205213-00",
  "strengths": [
    "100.0000",
    "500.0000",
    "20.0000",
    "3.0000",
    "5.0000",
    "7.2200"
  ],
  "pack_count": 13,
  "substances": [
    "Potassium Hydrogen Carbonate",
    "Sodium Alginate",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate",
    "Saccharin Sodium",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Alginic Acid",
  "authorisation_numbers": [
    "BE205213"
  ]
}
API referenceMCP serverPlans

See everything about alginic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console